Presidential Select Symposium will examine biologic links between stress and cancer
AACR President David A. Tuveson will chair the symposium titled: Aging, Stress, and Cancer.
AACR President David A. Tuveson will chair the symposium titled: Aging, Stress, and Cancer.
AACR President David A. Tuveson says clinicians will be ready and waiting before the cancer appears in the future
Researchers have found that a third COVID-19 vaccine increases vaccine effectiveness
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics
Companies will showcase combined solution at American Association for Cancer Research (AACR) Annual Meeting 2022
Scientific Solutions business splits from global medtech company
Rice process customizes one-, two- or three-element doping for applications
The new technology hopes to help patients in remote areas across the world, through deep learning
Increased levels of blood fats in people with type 2 diabetes and obesity are more harmful than previously thought, a new study has found
A substantial increase in deaths in care homes in the first three months of the pandemic is likely to have contributed to the figure
Software which helps speed up the process of creating new diagnostic tests could help combat future pandemics, its developers say.
The service aims to support the discovery and early pre-clinical development of RNA-based therapeutics and vaccines.
Unhealthy lifestyles are associated with a higher risk of severe COVID-19, but risks are highest in the most economically disadvantaged, according to a new study
The Dianthus instrument includes breakthrough Spectral Shift technology for affinity-based screenings in drug discovery
Pipetting robot has helped an Arbovirus testing lab streamline its sample pooling and reduce the use of plastic labware
Scientists have identified a protein, GIT1, as a modulator of Notch signaling and a guardian against breast cancer growth
Research confirms the unmet need for an effective alternative to unenhanced MRI and a safe alternative to GBCAs
Research finds patients with ASXL1 have distinctive epigentic changes that can activate harmful genes